Development of a novel animal model to investigate the role of cholesterol metabolism in the development and differentiation

开发一种新型动物模型来研究胆固醇代谢在发育和分化中的作用

基本信息

  • 批准号:
    10557104
  • 负责人:
  • 金额:
    $ 8.7万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Squalene synthase (SS) catalyzes the reductive head-to-head condensation of two molecules of farnesyl diphosphate (FPP) to form squalene, the first specific intermediate in the cholesterol biosynthetic pathway. We used gene targeting to knock out the mouse SS gene. The mice heterozygous for the mutation (SS+/-) were apparently normal. SS+/- mice showed 60% reduction in the hepatic mRNA levels of SS compared to SS+/+mice. Consistently, the SS enzymatic activities were reduced by 50% in the liver and testis. Nevertheless, the hepatic cholesterol synthesis was not different between SS+/- and SS+/+ mice and plasma lipoprotein profiles were not different irrespective of the presence of the LDL receptor, indicating that SS is not a rate-limiting enzyme in the cholesterol biosynthetic pathway. The mice homozygous for the disrupted SS gene (SS-/-) were embryonic lethal around midgestation. E9.5-10.5 SS-/- embryos exhibited severe growth retardation and defective neural tube closure. The lethal phenotype was not rescued by supplementing the dams either with dietary squalene or cholesterol. We speculate that cholesterol is required for the development, particularly, of nervous system, and that the chorioallantoic circulatory system is not mature enough to supply the rapidly growing embryos with maternal cholesterol at this developmental stage.
角鲨烯合酶(SS)催化两个分子的法呢基二磷酸(FPP)的还原性头对头缩合以形成角鲨烯,角鲨烯是胆固醇生物合成途径中的第一个特异性中间体。我们使用基因靶向敲除小鼠SS基因。突变杂合子(SS+/-)小鼠明显正常。与SS+/+小鼠相比,SS+/-小鼠显示SS的肝脏mRNA水平降低60%。肝脏和睾丸中SS酶活性降低50%。然而,SS+/-和SS+/+小鼠之间的肝脏胆固醇合成没有差异,并且无论是否存在LDL受体,血浆脂蛋白谱都没有差异,表明SS不是胆固醇生物合成途径中的限速酶。SS基因纯合子小鼠(SS-/-)在妊娠中期左右是胚胎致死的。E9.5-10.5 SS-/-胚胎表现出严重的生长迟缓和有缺陷的神经管闭合。通过向母鼠补充膳食角鲨烯或胆固醇,致死表型没有得到挽救。我们推测,胆固醇是必需的发展,特别是神经系统,和绒毛尿囊循环系统是不够成熟,以提供快速增长的胚胎与母体胆固醇在这个发展阶段。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gotoda T, Iizuka Y, Kato N, Osuga J, Bihoreau MT, Murakami T, Yamori Y, Shimano H, Ishibashi S. Yamada N.: "Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance."Nat. Genet.. 22. 226-228 (1999)
Gotoda T、Iizuka Y、Kato N、Osuga J、Bihoreau MT、Murakami T、Yamori Y、Shimano H、Ishibashi S. Yamada N.:“具有胰岛素抵抗的原始自发性高血压大鼠中不存在 Cd36 突变。”Nat。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimano H, Ishibashi S, et al.: "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes"J. Biol. Chem.. 274. 35832-35839 (1999)
Shimano H,Ishibashi S,等人:“甾醇调节元件结合蛋白-1作为脂肪生成酶基因营养诱导的关键转录因子”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama J, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N, Ishikawa F.: "The presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice."Genes Cells. 4
Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama J, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N, Ishikawa F.:“端粒 G 链尾部的存在
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Gotoda T, Ishibashi S, et al.: "Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance"Nat. Genet.. 22. 226-8 (1999)
Gotoda T、Ishibashi S 等人:“具有胰岛素抵抗的原始自发性高血压大鼠中不存在 Cd36 突变”Nat。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tozawa R, Ishibashi S, Osuga J, Yagyu H, Oka T, Chen Z, Ohashi K, Perrey S, Shionoiri F, Yahagi N, Harada K, Gotoda T, Yazaki Y, Yamada: "Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase"J. Biol. Chem.. 274. 30843-30
Tozawa R、Ishibashi S、Osuga J、Yagyu H、Oka T、Chen Z、Ohashi K、Perrey S、Shionoiri F、Yahagi N、Harada K、Gotoda T、Yazaki Y、Yamada:“胚胎致死性和有缺陷的神经管闭合
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIBASHI Shun其他文献

ISHIBASHI Shun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIBASHI Shun', 18)}}的其他基金

Study on the endoplasmic stress induced by oxsterol ester and its implication to diseases
氧甾醇酯诱导的内质应激及其疾病意义的研究
  • 批准号:
    22390187
  • 财政年份:
    2010
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of novel functions of cholesterol and its metabolites using genetic manipulation in mice
利用小鼠基因操作阐明胆固醇及其代谢物的新功能
  • 批准号:
    17390266
  • 财政年份:
    2005
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New therapeutic targets for atherosclerotic plaques - The role of acyl CoA : cholesterol acyltransferase and neutral cholesterol ester hydrolase in foam cell formation
动脉粥样硬化斑块的新治疗靶点 - 酰基辅酶A的作用:胆固醇酰基转移酶和中性胆固醇酯水解酶在泡沫细胞形成中的作用
  • 批准号:
    12557092
  • 财政年份:
    2000
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Transgenic study on the heterogeneity of intacellular triacylglycerol lipase
细胞内三酰甘油脂肪酶异质性的转基因研究
  • 批准号:
    11470232
  • 财政年份:
    1999
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of basic techniques for the liver-directed gene therapy
肝脏定向基因治疗基础技术的开发
  • 批准号:
    07557071
  • 财政年份:
    1995
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似国自然基金

PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
  • 批准号:
    81302714
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of cholesterol biosynthesis in CAF for tumorigenesis
CAF 中胆固醇生物合成对肿瘤发生的作用
  • 批准号:
    23K14585
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Reducing the production of toxic Abeta peptides in Alzheimer's disease by mutating the APP cholesterol-binding site: a new therapeutic strategy?
通过突变 APP 胆固醇结合位点来减少阿尔茨海默病中有毒 Abeta 肽的产生:一种新的治疗策略?
  • 批准号:
    MR/Y013859/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Research Grant
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
  • 批准号:
    10733720
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
  • 批准号:
    10585773
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
Cholesterol homeostasis in the vertebrate retina
脊椎动物视网膜中的胆固醇稳态
  • 批准号:
    10580969
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
  • 批准号:
    10678459
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
NASH 中胆固醇稳态与炎症消退之间的干扰串扰
  • 批准号:
    10568478
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
Understanding of cholesterol transporter mechanisms via HS-AFM and computational modeling
通过 HS-AFM 和计算模型了解胆固醇转运机制
  • 批准号:
    22KF0153
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Healthy Heart Remnant Cholesterol Tackles Diabetes in Youth
健康的心脏残余胆固醇可治疗青少年糖尿病
  • 批准号:
    499350
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
    Salary Programs
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
  • 批准号:
    10802975
  • 财政年份:
    2023
  • 资助金额:
    $ 8.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了